Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo
Authors
Keywords
-
Journal
Nature Chemical Biology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-11
DOI
10.1038/s41589-021-00786-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of a potent and selective covalent Pin1 inhibitor
- (2020) Benika J. Pinch et al. Nature Chemical Biology
- Synaptic Protein Degradation Controls Sexually Dimorphic Circuits through Regulation of DCC/UNC-40
- (2020) Yehuda Salzberg et al. CURRENT BIOLOGY
- An IRAK1–PIN1 signalling axis drives intrinsic tumour resistance to radiation therapy
- (2019) Peter H. Liu et al. NATURE CELL BIOLOGY
- Rapid covalent-probe discovery by electrophile-fragment screening
- (2019) Efrat Resnick et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A Dimethyl-Labeling-Based Strategy for Site-Specifically Quantitative Chemical Proteomics
- (2018) Fan Yang et al. ANALYTICAL CHEMISTRY
- Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor
- (2018) Matthew R. Janes et al. CELL
- Prolyl isomerase Pin1: a promoter of cancer and a target for therapy
- (2018) Yang Chen et al. Cell Death & Disease
- Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells
- (2018) Shingo Kozono et al. Nature Communications
- Post-translational modification localizes MYC to the nuclear pore basket to regulate a subset of target genes involved in cellular responses to environmental signals
- (2018) Yulong Su et al. GENES & DEVELOPMENT
- A Chemoproteomic Strategy for Direct and Proteome-Wide Covalent Inhibitor Target-Site Identification
- (2018) Christopher M. Browne et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action
- (2017) Elena Campaner et al. Nature Communications
- Proteome-wide covalent ligand discovery in native biological systems
- (2016) Keriann M. Backus et al. NATURE
- High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines
- (2016) Channing Yu et al. NATURE BIOTECHNOLOGY
- Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
- (2016) Maxim V. Kuleshov et al. NUCLEIC ACIDS RESEARCH
- Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc
- (2016) Luana D’Artista et al. Oncotarget
- Synergy between loss of NF1 and overexpression of MYCN in neuroblastoma is mediated by the GAP-related domain
- (2016) Shuning He et al. eLife
- ProLuCID: An improved SEQUEST-like algorithm with enhanced sensitivity and specificity
- (2015) T. Xu et al. Journal of Proteomics
- Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer
- (2015) Shuo Wei et al. NATURE MEDICINE
- Structure-based design of novel human Pin1 inhibitors (III): Optimizing affinity beyond the phosphate recognition pocket
- (2014) Chuangxing Guo et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Covalent docking of large libraries for the discovery of chemical probes
- (2014) Nir London et al. Nature Chemical Biology
- Pin1 inhibitors: Pitfalls, progress and cellular pharmacology
- (2013) Jonathan D. Moore et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast
- (2013) Alessandra Rustighi et al. EMBO Molecular Medicine
- Pin1 Regulates the Dynamics of c-Myc DNA Binding To Facilitate Target Gene Regulation and Oncogenesis
- (2013) A. S. Farrell et al. MOLECULAR AND CELLULAR BIOLOGY
- The rs2233678 Polymorphism in PIN1 Promoter Region Reduced Cancer Risk: A Meta-Analysis
- (2013) Qi Li et al. PLoS One
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Neutrophil-mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model
- (2012) Shuning He et al. JOURNAL OF PATHOLOGY
- A Pin1/Mutant p53 Axis Promotes Aggressiveness in Breast Cancer
- (2011) Javier E. Girardini et al. CANCER CELL
- Genetically engineered murine models – Contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma
- (2011) Louis Chesler et al. SEMINARS IN CANCER BIOLOGY
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Structure-based design of novel human Pin1 inhibitors (II)
- (2010) Liming Dong et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pin1 expression contributes to lung cancer prognosis and carcinogenesis
- (2010) Xiaogang Tan et al. CANCER BIOLOGY & THERAPY
- Structure-based design of novel human Pin1 inhibitors (I)
- (2009) Chuangxing Guo et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Inhibition of the Peptidyl-Prolyl-Isomerase Pin1 Enhances the Responses of Acute Myeloid Leukemia Cells to Retinoic Acid via Stabilization of RAR and PML-RAR
- (2009) M. Gianni' et al. CANCER RESEARCH
- Juglone Inactivates Cysteine-rich Proteins Required for Progression through Mitosis
- (2008) Claudia Fila et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability
- (2008) Prudence B Lam et al. Molecular Cancer
- Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance
- (2008) Tae Ho Lee et al. NATURE CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now